Copyright
©The Author(s) 2018.
World J Gastroenterol. Jul 7, 2018; 24(25): 2733-2740
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2733
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2733
Figure 4 Transforming growth factor-β can promote the proliferation of tumor cells and increase the level of interleukin-6 in hepatocellular carcinoma cell lines production.
A: The cell numbers of the three HCC cell lines after treatment with 100 ng/mL rhTGF-β for 48 h; B: The three HCC culture supernatants were analyzed for protein levels of IL-6 after treatment with rhTGF-β for 48 h using ELISA; C: The three HCC cell lines were treated with or without rhIL-6 for 48 h, and cell proliferation was determined by MTT assay. aP < 0.05, bP < 0.01, cP < 0.001. TGF-β: Transforming growth factor-β; Treg: Regulatory cells; HCC: Hepatocellular carcinoma.
- Citation: An Y, Gao S, Zhao WC, Qiu BA, Xia NX, Zhang PJ, Fan ZP. Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma. World J Gastroenterol 2018; 24(25): 2733-2740
- URL: https://www.wjgnet.com/1007-9327/full/v24/i25/2733.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i25.2733